Rest Of Europe Allergy Diagnostics Market (2026-2031)
The Rest Of Europe Allergy Diagnostics Market was valued at $492.7 Million in 2026 and projected to reach to $838.3 Million by 2031, representing a compound annual growth rate of 11.2%. Rest of Europe represents a high-growth segment within the broader European allergy diagnostics landscape, driven by increasing prevalence of allergic conditions and improving healthcare infrastructure in emerging economies.
Rest Of Europe Allergy Diagnostics Market Trends and Insights
- In 2026, Other Countries/Regions is estimated at USD 492.7 million, demonstrating substantial market potential across emerging and developing economies.
- The region is projected to expand to USD 838.3 million by 2031, reflecting a compound annual growth rate of 11.2%—outpacing global averages and indicating accelerating adoption of allergy diagnostic solutions. The expansion of Other Countries/Regions is driven by increasing healthcare infrastructure investment, rising allergy prevalence, and growing awareness of diagnostic testing benefits.
- Other Countries/Regions benefits from improving access to advanced diagnostic technologies and expanding healthcare spending in middle-income markets.
- Between 2026 and 2031, Other Countries/Regions is expected to capture growing demand from both urban centers and emerging healthcare systems seeking cost-effective allergy diagnostic solutions. Other Countries/Regions' robust growth trajectory underscores the region's importance as a high-potential market within the broader Middle East Africa landscape.
- The 11.2% CAGR for Other Countries/Regions reflects favorable demographic trends, regulatory improvements, and increasing patient awareness driving market expansion through 2031..
Key Market Statistics
- CAGR (2026-2031) 11.2% CAGR
- Market Size, 2026 ~USD 492.7 Million
- Forecast, 2031 ~USD 838.3 Million
- Country Rest Of Europe
Rest Of Europe Allergy Diagnostics Market Overview
Strong Regional Growth :
Rest of Europe's allergy diagnostics market is projected to grow from USD 492.7 million in 2026 to USD 838.3 million by 2031, representing an 11.2% CAGR that outpaces the global average of 9.6%.
Emerging Market Potential :
Smaller European economies and developing regions demonstrate significant untapped opportunities for allergy diagnostic expansion, driven by increasing healthcare awareness and diagnostic accessibility improvements.
Healthcare Infrastructure Development :
Rising investments in healthcare systems across Rest of Europe countries are enabling better diagnostic capabilities and improved patient access to allergy testing services.
Regulatory Harmonization Benefits :
Alignment with European healthcare standards and regulations is facilitating market entry and expansion for diagnostic providers in smaller European markets.
Rest Of Europe Allergy Diagnostics Market Dynamics
- The region's 11.2% CAGR significantly exceeds global growth rates, indicating accelerating adoption of diagnostic technologies and rising healthcare spending.
- Market expansion is supported by growing awareness of allergy management and diagnostic importance among healthcare providers and patients.
- By 2031, the market is expected to reach USD 838.3 million, reflecting substantial investment opportunities and competitive dynamics.
- Key drivers include population growth, urbanization, and enhanced access to diagnostic services across smaller European nations and developing regions..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Other Countries/Regions allergy diagnostics market valued at USD 492.7 million in 2026, expanding to USD 838.3 million by 2031.
- Other Countries/Regions demonstrates 11.2% CAGR, outpacing global growth and indicating strong market momentum.
- Other Countries/Regions benefits from rising healthcare infrastructure investment and increasing allergy prevalence awareness.
- Other Countries/Regions represents a high-potential emerging market within Middle East Africa with favorable demographic and regulatory tailwinds.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
Rest Of Europe Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Device Manufacturers : Need market-specific insights to develop targeted product strategies, identify distribution partnerships, and allocate R&D resources for Rest of Europe expansion.
- Healthcare Investment Firms : Require detailed market analysis and growth forecasts to evaluate investment opportunities, assess portfolio companies, and identify acquisition targets in the region.
- Healthcare Providers & Laboratories : Seek market intelligence to understand demand trends, competitive positioning, and service expansion opportunities within Rest of Europe allergy diagnostics.
- Market Entry & Expansion Teams : Need region-specific data to develop go-to-market strategies, assess market viability, and plan resource allocation for Rest of Europe market penetration.
- Strategic Consultants & Analysts : Require comprehensive market data and forecasts to support client advisory work, competitive analysis, and strategic planning in European allergy diagnostics.
Key Companies in the Rest Of Europe Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- Identify High-Growth Opportunities : Pinpoint emerging markets within Rest of Europe with the strongest growth potential and earliest market entry windows for allergy diagnostic solutions and services.
- Competitive Positioning Strategy : Understand regional market dynamics, competitive landscape, and differentiation strategies specific to smaller European economies to optimize market penetration and positioning.
- Investment Decision Support : Access detailed market sizing and forecasts to support capital allocation decisions, partnership evaluations, and expansion planning in Rest of Europe regions.
- Regulatory & Market Access Insights : Gain clarity on healthcare regulations, reimbursement frameworks, and market entry requirements specific to Rest of Europe countries for faster commercialization.
- Revenue Forecasting Accuracy : Leverage region-specific CAGR data and market projections to build accurate financial models and revenue forecasts for Rest of Europe operations and investments.
Frequently asked questions
What is the market size of allergy diagnostics in Other Countries/Regions?
Other Countries/Regions allergy diagnostics market is estimated at USD 492.7 million in 2026 and is projected to reach USD 838.3 million by 2031.
What is the growth rate for Other Countries/Regions allergy diagnostics market?
Other Countries/Regions is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2026 to 2031.
What factors are driving growth in Other Countries/Regions?
Other Countries/Regions growth is driven by increasing healthcare infrastructure investment, rising allergy prevalence, expanding healthcare spending, and growing patient awareness of diagnostic testing benefits.
How does Other Countries/Regions compare to global market growth?
Other Countries/Regions CAGR of 11.2% outpaces the global allergy diagnostics market CAGR of 9.6%, indicating stronger regional growth momentum.
What is the forecast market size for Other Countries/Regions by 2031?
Other Countries/Regions allergy diagnostics market is forecasted to reach USD 838.3 million by 2031, representing a USD 345.6 million increase from 2026.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report